Case Reports in Oncology (Dec 2023)

Long-Term Treatment of Unresectable Pseudomyxoma Peritonei with Multiple Treatments of Intratumoural Bromelain and Acetylcysteine (BromAc®): A Case Report

  • Jessica Yang,
  • Derek Glenn,
  • Suhrid Lodh,
  • Sarah Valle,
  • David Lawson Morris

DOI
https://doi.org/10.1159/000534202
Journal volume & issue
Vol. 16, no. 1
pp. 1551 – 1556

Abstract

Read online

Pseudomyxoma peritonei is a rare peritoneal malignancy characterized by the progressive accumulation of mucinous material and tumour within the abdomen and pelvis. Percutaneous drainage of mucin may be a non-surgical option for relief of symptoms; however, it remains difficult due to the high viscosity of mucin, with numerous case reports reporting difficulty removing material through medium-bore catheters alone. BromAc is a therapy currently undergoing development which dissolves mucinous tumour masses and allows for extraction. This report describes the case of a patient who has had multiple treatments with BromAc over 4 years.

Keywords